MLAB News and Press, Mesa Laboratories Inc. From 11/06/23

2023-11-06 08:12:50 ET More on Mesa Laboratories Mesa Laboratories: Continued Pressure On Equity Re-Rating, Reiterate Hold Mesa Labs buys three GKE entities for €85M to boost revenue Seeking Alpha’s Quant Rating on Mesa Laboratories Historical e...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

Mesa Laboratories Inc. (MLAB) is expected to report $1.1 for Q2 2024

2023-10-16 03:15:08 ET More on Mesa Laboratories Mesa Laboratories: Continued Pressure On Equity Re-Rating, Reiterate Hold Mesa Laboratories (MLAB) Investor Presentation - Slideshow Seeking Alpha’s Quant Rating on Mesa Laboratories Dividend scorecard f...

Lakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today annou...

LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, 2023. About Mesa Laboratories, Inc. Mesa ...

LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced its commitment to calculate a...

2023-08-23 23:09:53 ET Summary Mesa Laboratories, Inc. still faces profitability concerns despite a balanced Q1 FY'24 performance. MLAB's stock has experienced a significant decline, wiping out five years of equity gains in around 12 months or so. MLAB needs to overcome challe...

2023-08-03 08:04:58 ET Mesa Laboratories press release ( NASDAQ: MLAB ): Q1 Non-GAAP EPS of $1.77 beats by $0.27 . Revenue of $50.65M (+0.4% Y/Y) misses by $0.92M . For further details see: Mesa Laboratories Non-GAAP EPS of $1.77 beats by $0.27, revenue o...

LAKEWOOD, Colo., June 21, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Thursday, August 3, 2023. About Mesa Laboratories, Inc. Mesa is a...